you are making a big mistake to expect that....they already said that the data will be "mediocre" because of the composition....it is not made for doctors offices...it is made for pharma trials...so number in the 70-80 are most likely and NOT in the 90!!!
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links